Craft

Akoya Biosciences

Stock Price

$2.8

2024-10-29

Market Capitalization

$143.5 M

2024-10-29

Revenue

$81.7 M

FY, 2024

Akoya Biosciences Summary

Company Summary

Overview
Akoya Biosciences is a biotechnology company specializing in high-parameter tissue analysis. It offers two platforms that allow investigators and researchers to gain a deeper understanding of cancer, autoimmune and neurological diseases. The CODEX system is a benchtop platform that can quantify more than 40 protein biomarkers and helps with biomarker discovery. The Phenoptics platform is an immunofluorescence solution for translational research and clinical trials.
Type
Public
Status
Active
Founded
2015
HQ
Marlborough, MA, US | view all locations
Website
https://www.akoyabio.com/
Cybersecurity rating
Sectors

Key People

  • Brian McKelligon

    Brian McKelligon, Chief Executive Officer

  • Nikolay Samusik
  • Yury Goltsev

    Yury Goltsev, Co-Founder

    • Joe Driscoll

      Joe Driscoll, Chief Financial Officer

    Operating MetricsView all

    Instrument Placements

    60
    93.5%

    Q2, 2022

    Facility Space Leased, sq. ft.

    69.5K
    99.4%

    FY, 2021

    Patents Issued (US)

    17
    6.3%

    FY, 2021

    LocationsView all

    2 locations detected

    • Marlborough, MA HQ

      United States

      100 Campus Dr 6th floor, Marlborough

    • Menlo Park, CA

      United States

      1080 O'Brien Dr suite a

    Akoya Biosciences Financials

    Summary Financials

    Revenue (Q1, 2025)
    $16.6M
    Gross profit (Q1, 2025)
    $9.9M
    Net income (Q1, 2025)
    ($15.7M)
    Cash (Q1, 2025)
    $20.4M
    EBIT (Q1, 2025)
    ($13.4M)
    Enterprise value
    $276.2M

    Footer menu